Harvard BioscienceHBIO
13F holders, Q3 2025 (September 30)1holders −1
0new positions
1sold out
$0.44avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Harvard Bioscience Inc. (HBIO) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holder was Pension & Wealth Management Advisors, Inc. ($987).
- Company
- Harvard Bioscience Inc.
- CUSIP
- 416906204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $39 |
All 13F filers, Q2 2025 → Q3 2025: 3,787 shares sold, net −3,787 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Pension & Wealth Management Advisors, Inc. | 0.00% | Reduce -62.2% | 2,250 | $987 |
"% of holder's portfolio" is HBIO's weight in each manager's 13F, not the share of Harvard Bioscience Inc. the manager owns.